Patent application of Chinese traditional medicine abroad only accounts for 0.3% of the market and only 5% of the market
-
Last Update: 2012-04-18
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Traditional Chinese medicine (TCM) is the dominant field with independent intellectual property rights in China, but the foreign patent application of TCM in China only accounts for 0.3% Japan and South Korea have already taken the lead and occupied more than 70% of the international market of Chinese patent medicine Last weekend, at the first "Shennong medical doctor forum" of Guangzhou Pharmaceutical Group, experts at the meeting called for the urgent protection of patent of traditional Chinese medicine According to the relevant data, China only accounts for 5% of the $30 billion international market of traditional Chinese medicine Among the embarrassing 5%, about 70% are Chinese medicinal materials Chinese patent medicines with high technology added value are not only exported in a small amount, but also difficult to obtain the protection of the Western patent system They are in danger of being imitated in international trade The situation of patent application of enterprises in domestic market is not optimistic According to Zhang Qingkui, director of the State Intellectual Property Office, nearly half of the patent applications for traditional Chinese medicine in China are filed by individuals Many traditional Chinese medicine enterprises have focused on the protection and registration of traditional Chinese medicine varieties before, thus wasting many opportunities In China, the intellectual property rights of brand traditional Chinese medicine also need attention According to Li Chuyuan, general manager of Guangyao group, Guangyao group attaches great importance to the protection of intellectual property rights So far, Guangyao group has 6 time-honored Chinese enterprises and 2 well-known trademark enterprises Among them, Baiyunshan compound danshen tablet has more than ten patent protections in raw materials, production technology, clinical use and product packaging At present, it has become the first brand of its kind, with an annual sales volume of 3.8 billion pieces, accounting for half of the country.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.